Abstract A128: Design of a Phase 2 basket trial to assess mifomelatide (TCMCB07) in GI cancer cachexia: A focus on pancreatic ductal adenocarcinoma (PDAC)
Background: Cachexia is common in gastrointestinal (GI) cancers in general and pancreatic ductal adenocarcinoma (PDAC) in particular. PDAC has one of the highest prevalences and earliest onsets of cancer cachexia, affecting up to 90% of patients. Furthermore, the extent of weight lost among patients with PDAC exceeds...